Vitro Biopharma, Inc. (VTRO)

Vitro Biopharma will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$5.00 - $6.00

Shares Offered

1,000,000

Deal Size

$5.50M

Vitro Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Operating Activities

Year Ending	TTM	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Net Income	-4.2	-4.76	-1.64
Depreciation & Amortization	0.21	0.16	0.15
Share-Based Compensation	-	2.04	0.27
Other Operating Activities	2.46	1.32	0.36
Operating Cash Flow	-1.53	-1	-0.78
Operating Cash Flow Growth	-	-	-

Investing Activities

Year Ending	TTM	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Capital Expenditures	-0.21	-0.03	-0.03
Acquisitions	-	0.37	-
Investing Cash Flow	0.15	0.34	-0.03

Financing Activities

Year Ending	TTM	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Share Issuance / Repurchase	-	1.79	1.03
Debt Issued / Paid	-	2.95	-0.04
Financing Cash Flow	3.56	4.74	0.98

Net Cash Flow

Year Ending	TTM	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Net Cash Flow	2.18	4.08	0.18

Free Cash Flow

Year Ending	TTM	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Free Cash Flow	-1.75	-1.03	-0.81
Free Cash Flow Growth	-	-	-
Free Cash Flow Margin	-56.97%	-78.66%	-124.13%